GRACE :: Lung Cancer
Denise Brock

Targeted Therapies in Lung Cancer Patient Forum 2017 – It’s a Wrap!

 

On Saturday, September 16, 2017, patients, caregivers, family members and friends joined GRACE in Cleveland at the Taussig Cancer Center for a full day of discussion on Targeted Therapies in Lung Cancer.  We are thrilled that people joined us for this amazing and informative day.  Huge thanks to all of the faculty who spent their Saturday in Cleveland with our community, and thanks also to those organizations who sponsored this event – Astra Zeneca, Takeda, Boehringer Ingelheim, Ignyta, Novartis, Genentech, Caris, and Guardant Health.  

 

We started the day out with a warm welcome from our Forum Chair – Dr. Nathan Pennell.  For the full agenda, faculty list, presentations, and videos from the webcast, please visit the ‘webcast details’ page, available via this link.     

  Brain Power

The morning sessions continued:

The Many Faces of Progression
 Dr. Nathan Pennell
 Cleveland Clinic Cancer Center
The Role of Local Therapy
 Dr. Shirish Gadgeel
 Michigan Medicine, University of Michigan
 Biopsies & Re-biopsies
 Dr. Karen Reckamp
 City of Hope Comprehensive Cancer Center 
The Question of Clinical Trials
 Dr. Alice Shaw
 Massachusetts General Hospital
 The Crossroads:
 Local Therapy, Chemo, Targeted  Therapy, or Immunotherapy?
 Panel Discussion with Drs. Pennell,  Gadgeel, Reckamp, and Shaw,
 and patients John Cherol (EGFR), Matt  Hiznay (ALK),
 and Sara Whitlock (RET).
 Moderator: Dr. H. (Jack) West 
 
 
 
Lunch was an opportunity to have further discussion with the faculty.  Cleveland Clinic Cancer Center graciously allowed us to set up lunch on the 1st floor in their beautiful new facility.

 
 
 
 
After lunch the breakout discussions continued: 
 
ALK/ROS1
 Dr. Alice Shaw, Dr. Shirish Gadgeel,
 and Matt Hiznay, ALK patient
 EGFR
 Dr. Nathan Pennell, Dr. H. (Jack) West,
 and John Cherol, EGFR patient
 MET/RET/BRAF
 Dr. Karen Reckamp, Dr. Vamsidhar  Velcheti, and Sara Whitlock, RET patient 
 
The day concluded with the afternoon general session: 
Managing the Cost of Cancer Care
 Dr. James P. Stevenson
 Cleveland Clinic Cancer Center
 Patient to Patient Mentoring
 Kathryn Sefcek, MHA
 4th Angel Mentoring Program
 Caveat Emptor: Assessing Cancer Information from Sources of  Varying Quality  
 Dr. H. (Jack) West
 Swedish Cancer Institute & Founder of  cancerGRACE
 and Janet Freeman-Daily, ROS1 patient,  #LCSM Twitter Chat co- moderator, Cure  Today contributor, blogger
 

Please click here to visit the Targeted Therapies in Lung Cancer Webcast page for viewing the videos in full!  (Please note, we will be editing the videos to cut them down – they are in raw format at this time).

 

 

Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

 


Denise Brock

ASCO 2017 – Lung Cancer – What is the role for Immunotherapy in Relapsed Small Cell Lung Cancer after ASCO 2017?

H. Jack West, MD
Medical Director
Thoracic Oncology Program Swedish Cancer Institute
President & CEO, GRACE
Matthew Gubens, MD
Thoracic Oncologist
Thoracic Surgery and Oncology Clinic
UCSF Helen Diller Family Comprehensive Cancer Center
Jyoti D. Patel, MD
Director Thoracic Oncology
University of Chicago Medicine

 

Drs. H. Jack West, Medical Director of the Thoracic Oncology Program at Swedish Cancer Institute in Seattle, Washington and President and CEO of GRACE, Matthew Gubens, Thoracic Oncologist at the Thoracic Surgery and Oncology Clinic of the UCSF Helen Diller Family Comprehensive Center in San Francisco, California, and Jyoti Patel, Director of Thoracic Oncology at University of Chicago Medicine gathered post meeting to discuss new information from ASCO 2017 regarding lung cancer.   In this roundtable video, the doctors discuss What is the role for Immunotherapy in Relapsed Small Cell Lung Cancer after ASCO 2017?



 

 Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

  
   
                   

 


Denise Brock

ASCO 2017 – Lung Cancer – Emerging Options for Malignant Pleural Mesothelioma

H. Jack West, MD
Medical Director
Thoracic Oncology Program Swedish Cancer Institute
President & CEO, GRACE
Matthew Gubens, MD
Thoracic Oncologist
Thoracic Surgery and Oncology Clinic
UCSF Helen Diller Family Comprehensive Cancer Center
Jyoti D. Patel, MD
Director Thoracic Oncology
University of Chicago Medicine

 

Drs. H. Jack West, Medical Director of the Thoracic Oncology Program at Swedish Cancer Institute in Seattle, Washington and President and CEO of GRACE, Matthew Gubens, Thoracic Oncologist at the Thoracic Surgery and Oncology Clinic of the UCSF Helen Diller Family Comprehensive Center in San Francisco, California, and Jyoti Patel, Director of Thoracic Oncology at University of Chicago Medicine gathered post meeting to discuss new information from ASCO 2017 regarding lung cancer.   In this roundtable video, the doctors discuss Emerging Options for Malignant Pleural Mesothelioma.



 

 Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

  
   
                   

 


Denise Brock

ASCO 2017 – Lung Cancer – Continuing Immunotherapy Beyond Progression

H. Jack West, MD
Medical Director
Thoracic Oncology Program Swedish Cancer Institute
President & CEO, GRACE
Matthew Gubens, MD
Thoracic Oncologist
Thoracic Surgery and Oncology Clinic
UCSF Helen Diller Family Comprehensive Cancer Center
Jyoti D. Patel, MD
Director Thoracic Oncology
University of Chicago Medicine

 

Drs. H. Jack West, Medical Director of the Thoracic Oncology Program at Swedish Cancer Institute in Seattle, Washington and President and CEO of GRACE, Matthew Gubens, Thoracic Oncologist at the Thoracic Surgery and Oncology Clinic of the UCSF Helen Diller Family Comprehensive Center in San Francisco, California, and Jyoti Patel, Director of Thoracic Oncology at University of Chicago Medicine gathered post meeting to discuss new information from ASCO 2017 regarding lung cancer.   In this roundtable video, the doctors discuss Continuing Immunotherapy Beyond Progression.



 

 Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

  
   
                   

 


Denise Brock

Lung Cancer Video Library – SCLC – Novel Therapies In Small Cell Lung Cancer (SCLC): Lurbinectedin

 

GRACE Cancer Video Library - Lung

 

H. Jack West, MD
President & CEO, GRACE

 

We are pleased to have GRACE’s Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute in Seattle, Washington, and President and CEO of GRACE bring 2017 updates to our Lung Cancer Video Library.  

In this latest video, Dr. West discusses exciting new advances in SCLC –  Novel Therapies In Small Cell Lung Cancer (SCLC): Lurbinectedin.  

 


 

 

 

 

How Did You Like This Video?

Please feel free to offer comments and raise questions in our Discussion Forums.


 We would like to thank the following companies for their support of this program

 

                

 

 

                        

 

 
 

 

 


  


Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243